Loading institutional data...
Loading institutional data...
Held by 344 of 5,944 reporting institutions (95th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $8.95 today, the market must believe free cash flow compounds 18.6%/yr for a decade (off $47M normalized FCF).
The market's 18.6% is more conservative than its 2-yr track record.
2-stage DCF · 0.24B shares · net debt -$15M
mean 1283.2% · volatility σ 1921% · implied rate exceeded in 1/2 yrs
Central path = implied 18.6%/yr growth; shaded band = ±1σ (1921%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $510.2M 100.0% | $426.5M 100.0% | $258.2M 100.0% | $154.1M 100.0% | $80.9M 100.0% | $42.2M 100.0% | $29.3M 100.0% | $17.0M 100.0% | $22.8M 100.0% | $10.7M 100.0% |
| Cost of Revenue | $217.4M 42.6% | $206.9M 48.5% | $169.3M 65.6% | $118.8M 77.1% | $79.8M 98.6% | $61.3M 145.2% | $39.5M 134.6% | $42.2M 248.4% | $29.2M 128.1% | $1.6M 15.1% |
| Cost of Products | — | — | — | — | — | — | — | — | $29.2M 128.1% | $6.4M 59.7% |
| Gross Profit | $292.8M 57.4% | $219.6M 51.5% | $88.9M 34.4% | $35.3M 22.9% | $1.2M 1.4% | -$19.1M -45.2% | — | -$25.2M -148.4% | -$6.4M -28.1% | $4.3M 40.3% |
| Research & Development | $4.8M 0.9% | $1.8M 0.4% | $3.3M 1.3% | $3.6M 2.3% | $3.6M 4.5% | $5.9M 14.0% | $2.3M 8.0% | $3.9M 23.1% | $5.6M 24.5% | $7.7M 72.1% |
| Selling, General & Admin | $91.6M 18.0% | $74.1M 17.4% | $59.0M 22.9% | $52.5M 34.0% | $42.9M 53.0% | $35.1M 83.0% | $25.9M 88.3% | $22.5M 132.5% | $18.8M 82.4% | $8.5M 79.7% |
| Total Operating Expenses | $101.3M 19.9% | $80.6M 18.9% | $67.3M 26.1% | $74.6M 48.4% | $59.5M 73.6% | $45.8M 108.6% | $70.8M 241.1% | $77.3M 454.9% | $62.1M 272.7% | $28.0M 262.6% |
| Operating Income | $191.4M 37.5% | $139.0M 32.6% | $21.6M 8.4% | -$39.4M -25.5% | -$58.4M -72.1% | -$64.9M -153.8% | -$41.4M -141.1% | -$60.3M -354.9% | -$39.3M -172.7% | -$17.3M -162.6% |
| Interest Expense | $7.1M 1.4% | $13.9M 3.3% | $25.0M 9.7% | $19.3M 12.5% | $13.1M 16.1% | $12.0M 28.4% | $9.0M 30.6% | $5.5M 32.5% | $3.3M 14.4% | $2.2M 21.0% |
| Interest & Investment Income | $1.9M 0.4% | $2.1M 0.5% | $1.6M 0.6% | $45K 0.0% | $35K 0.0% | $288K 0.7% | $801K 2.7% | $195K 1.2% | $57K 0.3% | $50K 0.5% |
| Other Income (Expense), net | -$8.8M -1.7% | -$13.3M -3.1% | -$49.9M -19.3% | -$26.5M -17.2% | -$13.3M -16.4% | -$10.8M -25.7% | -$6.9M -23.4% | -$5.5M -32.1% | -$4.4M -19.5% | -$2.2M -20.5% |
| Pretax Income | $182.7M 35.8% | $125.7M 29.5% | -$28.2M -10.9% | -$65.9M -42.8% | — | — | — | — | — | -$19.5M -183.1% |
| Income Tax Expense | $35.7M 7.0% | -$72.0M -16.9% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% |
| Net Income | $146.9M 28.8% | $197.7M 46.4% | -$28.2M -10.9% | -$65.9M -42.8% | -$71.7M -88.5% | -$75.7M -179.4% | -$48.3M -164.5% | -$65.7M -387.1% | -$43.8M -192.3% | -$19.5M -183.1% |
| Per Share | ||||||||||
| EPS (Basic) | $0.62 | $0.85 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | — | — | — | — |
| EPS (Diluted) | $0.60 | $0.81 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | — | — | — | — |
| Weighted Avg Shares (Basic) | 238.3M | 233.1M | 224.0M | 197.9M | 139.6M | 86.1M | — | — | — | — |
| Weighted Avg Shares (Diluted) | 244.9M | 243.3M | 224.0M | 197.9M | 139.6M | 86.1M | — | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $32M buybacks = $32M returned on $28M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 27%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $88M covers the $7M due within a year 12.5× over. Scheduled principal only (excludes interest & revolver draws). As of 2026-03-31 (10-Q).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~9.9% on $72M of debt.
Cash of $88M fully covers short-term debt of $3M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 13-yr range · 16th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 13-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 248.4 | 134.6 | 145.2 | 98.6 | 77.1 | 65.6 | 48.5 | 42.6 |
| Gross Profit | -148.4 | — | -45.2 | 1.4 | 22.9 | 34.4 | 51.5 | 57.4 |
| R&D | 23.1 | 8.0 | 14.0 | 4.5 | 2.3 | 1.3 | 0.4 | 0.9 |
| SG&A | 132.5 | 88.3 | 83.0 | 53.0 | 34.0 | 22.9 | 17.4 | 18.0 |
| Operating Income | -354.9 | -141.1 | -153.8 | -72.1 | -25.5 | 8.4 | 32.6 | 37.5 |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -16.9 | 7.0 |
| Net Income | -387.1 | -164.5 | -179.4 | -88.5 | -42.8 | -10.9 | 46.4 | 28.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ADMA: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| ADMA | $2.1B | 14.9× | 10.6× | 4.2× | 19.6% | 57.4% | 28.8% | 30.8% | 26.7% | 0.4× | 344 |
Peers = companies sharing ADMA's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.